Chen Xiao-Li, Ren Qian, Chen Zhen-Ping, Zhou Ze-Ping, Zhao Qin-Jun, Qiu Zhi-Yong, Dong Chun-Lan, Han Zhong-Chao
Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin 300020, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Apr;17(2):266-70.
Bmi-1 is a transcriptional repressor, which belongs to the polycomb group family. It has been demon- started that over-expression of Bmi-1 occurs in a variety of cancers, including several types of leukemia. Bmi-1 gene plays a key role in regulation of self-renewal in normal and leukemic stem cells. Acute myeloid leukemic cells lacking Bmi-1 undergo proliferation arrest and show signs of differentiation and apoptosis, which leads to the proposal of Bmi-1 as a potential target for therapeutic intervention in leukemia. The purpose of this study was to investigate the effect of short hairpin RNA (shRNA) targeting Bmi-1 on functions of K562 cell line. The shRNA eukaryotic expression vector targeting Bmi-1 was constructed and transfected into K562 cells through lipofectamine 2000. The mRNA and protein levels of Bmi-1 were detected by PCR and Western blot respectively. The proliferation of K562 after Bmi-1 silencing was measured by using MTT assay and clone formation assay. The cell cycle was detected by flow cytometry. The results indicated that among the four shRNA designed, there was a shRNA which efficiently interfered with the expression of Bmi-1. The results of PCR and Western blot validated that the Bmi-1 gene of K562 cells transfected with such a Bmi-1 shRNA was suppressed successfully. Although levels of Bmi-1 mRNA and protein were significantly reduced, delivery of this siRNAs had no effect on cell viability or growth. Flow cytometry analysis suggested that Bmi-1 inhibition did not affect the cell cycle. It is concluded that the suppression of Bmi-1 expression is not able to reduce proliferation of K562 cells, suggesting existence of some other parallel signaling pathways, which are fundamental for leukemic transformation and are independent of Bmi-1 over-expression. Bmi-1 over-expression may play a secondary role in chronic myeloid leukemia transformation.
Bmi-1是一种转录抑制因子,属于多梳蛋白家族。研究表明,Bmi-1在多种癌症中过度表达,包括几种类型的白血病。Bmi-1基因在正常和白血病干细胞的自我更新调节中起关键作用。缺乏Bmi-1的急性髓系白血病细胞会发生增殖停滞,并表现出分化和凋亡迹象,这使得Bmi-1成为白血病治疗干预的潜在靶点。本研究的目的是探讨靶向Bmi-1的短发夹RNA(shRNA)对K562细胞系功能的影响。构建了靶向Bmi-1的shRNA真核表达载体,并通过脂质体2000转染到K562细胞中。分别通过PCR和蛋白质免疫印迹法检测Bmi-1的mRNA和蛋白质水平。使用MTT法和克隆形成试验检测Bmi-1沉默后K562细胞的增殖情况。通过流式细胞术检测细胞周期。结果表明,在设计的四种shRNA中,有一种shRNA能有效干扰Bmi-1的表达。PCR和蛋白质免疫印迹法的结果证实,用这种Bmi-1 shRNA转染的K562细胞的Bmi-1基因被成功抑制。虽然Bmi-1的mRNA和蛋白质水平显著降低,但这种小干扰RNA的导入对细胞活力或生长没有影响。流式细胞术分析表明,抑制Bmi-1不会影响细胞周期。结论是,抑制Bmi-1的表达不能降低K562细胞的增殖,这表明存在一些其他平行信号通路,这些通路对于白血病转化至关重要且独立于Bmi-1的过度表达。Bmi-1的过度表达可能在慢性髓系白血病转化中起次要作用。